🧭 Bottom LineThere is no March 31 “trigger” for NWBO.The real situation is simpler:Everything hinges on the Medicines and Healthcare products Regulatory Agency reviewThat decision will come when the science + data review is completeNot when infrastructure, pilots, or calendars line upIf you want, I can walk you through: 👉 What approval would realistically do to the stock price (range scenarios)👉 Or what red flags would signal a delay or rejectionThose are much more useful than trying to decode exchange “signals.”